To elucidate the molecular mechanism by which NAT10 promotes CRC, we integrated multi-omics analysis of acRIP-seq, NaCNBH3-based chemical ac4C-seq, and RNA-seq data to identify direct targets of NAT10, demonstrating DKK2 as the pivotal NAT10 target. Here, NAT10 is linked to colorectal carcinoma.